José María de la Torre Hernández-rekin lankidetzan egindako argitalpenak (6)

2022

  1. Justificación y diseño del estudio Concordancia entre RFF e iFR en lesiones del tronco común.: Estudio iLITRO-EPIC-07

    REC: Interventional Cardiology, Vol. 4, Núm. 1, pp. 19-26

2021

  1. Antithrombotic strategies in elderly patients with atrial fibrillation revascularized with drug-eluting stents: PACO-PCI (EPIC-15) registry

    International Journal of Cardiology, Vol. 338, pp. 63-71

  2. Comparison of One-Year Outcomes Between the ihtDEStiny BD Stent and the Durable-Polymer Everolimus- and Zotarolimus-Eluting Stents: A Propensity-Score-Matched Analysis

    Cardiovascular Revascularization Medicine, Vol. 31, pp. 1-6

2020

  1. Estrategias de tratamiento antitrombótico en pacientes mayores de 75 años con fibrilación auricular tras intervencionismo coronario percutáneo con stents farmacoactivos: Registro PACO-PCI

    REC: Interventional Cardiology, Vol. 2, Núm. 4, pp. 322-323

2017

  1. Antithrombotic treatment during coronary angioplasty after failed thrombolysis: Strategies and prognostic implications. Results of the RESPIRE registry

    BMC Cardiovascular Disorders, Vol. 17, Núm. 1

2016

  1. The use of the acute Pd/Pa drop after intracoronary nitroglycerin infusion to rule out significant FFR: CANICA (Can intracoronary nitroglycerin predict fractional flow reserve without adenosine?) multicenter study

    Catheterization and Cardiovascular Interventions, Vol. 87, Núm. 2, pp. 262-269